EP2959894
S1P viðtakastillar til að meðhöndla heila- og mænusigg
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.6.2007EP published:
12.10.2022EP application number:
15177166.4
EP translation filed:
12.10.2022Grant published:
15.11.2022EPO information:
European Patent Register
Max expiry date:
24.6.2027Expiry date:
24.6.2026Next due date:
30.6.2026
Title in English:
S1P RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSISLanguage of the patent:
English
Timeline
Today
25.6.2007EP application
12.10.2022EP Publication
12.10.2022Translation submitted
15.11.2022Registration published
24.6.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
Hiestand, Peter C.Address:
4123 Allschwil, CH
Name:
Schnell, ChristianAddress:
68220 Hegenheim, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0612721Date:
27.6.2006Country:
GB
Classification
Categories:
A61K 31/137, A61P 37/06, A61K 31/397
Annual fees
Number
Paid
Expires
Payer
Number: 17
Paid: 24.5.2023
Expires: 24.6.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 23.5.2024
Expires: 24.6.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 12.6.2025
Expires: 24.6.2026
Payer: Árnason Faktor ehf.